Cellebrite DI

CLBT

greendotbot logoGreenDotBot AI Analysis

Business Overview / Sources of Revenue

Cellebrite DI Ltd. (NASDAQ: CLBT) is a global leader in digital intelligence solutions for law enforcement, governments, and enterprises[1][3]. The company develops technology that enables legally sanctioned investigations by providing tools to access, collect, review, extract, decode, decrypt, analyze, and manage digital data across the investigative lifecycle[4][5].

Cellebrite's core business revolves around its Digital Intelligence Suite of Forensic Solutions, which includes products like Inseyets for accessing mobile devices and extracting data, Guardian for securely managing digital evidence in the cloud, and Pathfinder for analyzing evidence from multiple sources[3]. These solutions help investigators reveal evidence up to twice as fast and extract up to 60% more data from digital devices[3].

The company serves various investigation types including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, and corporate security[4]. As of January 2025, Cellebrite has a market cap of $3.99 billion with annual revenue of $419.17 million[4].


Revenue Growth Potential and Recurrence

Cellebrite DI (CLBT) generates a large share of its revenue from recurring sources, primarily through subscriptions. In 2024, subscription revenue reached $353 million, accounting for nearly 88% of total revenue, and Annual Recurring Revenue (ARR) grew 25% year-over-year to $395.9 million[5]. The company’s dollar-based net retention rate stands at 124%, highlighting strong customer retention and expansion[5].

Looking forward, Cellebrite projects continued robust growth, guiding for 2025 ARR of $480–495 million (21–25% growth) and total revenue of $480–490 million (20–22% growth)[5][1]. This track record, combined with consistent double-digit ARR and revenue growth, positions the company for sustained expansion in the digital investigation market over the next five years, with expected annual growth rates in the low-to-mid-20% range[5][1][4].


Economic Moat Factors

Cellebrite DI (CLBT) demonstrates a strong and widening economic moat primarily built on high switching costs, as evidenced by its consistently high Net Revenue Retention rate above 120%[1]. The company's complementary products and services create a flywheel effect, making it difficult for customers to switch providers[1]. This integration strategy appears to be working effectively, as subscription revenue now accounts for 89% of total revenue[4], indicating strong customer loyalty.

Cellebrite's unique position in providing digital investigative solutions to government agencies like the FBI and CIA represents a specialized niche with high barriers to entry[5]. The company's ability to maintain 15%+ annual revenue growth while expanding globally further supports the strength of its competitive advantages[1].

This moat is translating to financial results, with ambitious targets including 24% CAGR in ARR and 20% CAGR in total revenues by 2028[5], suggesting the company's competitive position remains strong.


Leadership

Cellebrite DI's (CLBT) leadership is currently in transition. Thomas E. Hogan serves as interim CEO since January 2025, taking over after founder Yossi Carmil stepped down in December 2024 after nearly 20 years[3][5]. Hogan's total compensation is $3.7 million with CEO salary representing 4.04% of total, though his ownership stake is not available[2]. Adam H. Clammer serves as Chairman of the Board since January 2025[1][5]. The management team includes Dana Gerner (CFO) and Ronnen Armon (Chief Products & Technologies Officer)[2]. The management's average tenure is relatively short at 1.9 years compared to the board's 3.8 years[2].


Financial Health

Cellebrite DI (CLBT) has a very healthy balance sheet, holding $409.5 million in cash and zero debt, giving it a strong cash-to-debt ratio[5]. The company generates positive free cash flow, which is growing at 33.9% per year and provides a stable cash runway exceeding three years[5]. Cellebrite’s free cash flow margin is positive, reflecting solid cash generation, though the exact percentage is not specified. The company has not issued debt in the past five years and has not been dilutive with shares, indicating a shareholder-friendly approach[5].

Watch List

CRWD 104.69%
NTNX 54.28%
VEEV 14.34%
SNOW 51.88%
WDAY -7.60%
ENLT -4.95%
WEAV -17.62%
SE 48.81%
SPSC 20.84%
RDDT 14.77%
APPF 10.11%
CMG 44.89%
INTU 46.90%
PSTG 18.96%

Buy List

TBBB -32.59%
SEMR -31.87%
TSM -27.46%
ZETA -34.00%
GOOG -47.72%
ASR -27.56%
HRMY -52.49%
YOU -32.94%
ADBE -35.63%

Hold List

PINS -14.41%
ASML -15.40%
VTEX 5.60%
NYAX -19.42%
MSFT -15.81%
ODD 17.08%
FLYW -21.57%
CELH 29.32%
TOST 39.47%
CPNG 6.98%
HIMS 35.72%
PAYC 0.68%
MNDY 28.77%
GLBE -24.67%
ZS 78.83%
V 1.38%
ADSK 8.10%
NOW 22.31%
ABNB -24.99%
MELI -23.00%
FTNT 0.61%
TEAM -9.09%